土茯苓活性成分治疗银屑病的作用机制研究进展
Research Progress on the Mechanism of Action of the Active Ingredient of Rhizoma Smilacis Glabrae in the Treatment of Psoriasis
DOI: 10.12677/TCM.2023.1210437, PDF,   
作者: 张自薇：黑龙江中医药大学研究生院，黑龙江 哈尔滨
关键词: 土茯苓；银屑病；活性成分；作用机制；Rhizoma Smilacis Glabrae； Psoriasis； Active Ingredient； Mechanism of Action
摘要: 本文对近年来土茯苓治疗银屑病的中医认识、活性成分及作用机制进行综述。土茯苓具有清热解毒、除湿泄浊、通利关节等功效，其主要活性成分为总黄酮类、苯丙素类、糖类、无机盐、有机酸类、甾体、挥发油类、酚类和酚类苷等。药理研究证实，土茯苓具有免疫调节、抗炎、镇痛、抗增殖、抑制血管生成、修复皮肤屏障、调节肠道菌群等作用。可针对银屑病免疫调节紊乱、炎症感染、皮肤损伤、肠道菌群紊乱等发病机制而起到治疗作用，为临床应用提供科学依据。
Abstract: This paper reviews the traditional Chinese medicine understanding, active ingredients and mecha-nism of action of Rhizoma Smilacis Glabrae in the treatment of psoriasis in recent years. It has the effects of clearing heat and detoxification, dehumidifying and discharging turbidity, and easing joint movement. Its main active ingredients are total flavonoids, phenylpropanoids, sugars, inorganic salts, organic acids, steroids, volatile oils, phenols and phenolic glycosides. Pharmacological studies have confirmed that Rhizomasmilacisglabrae has immunomodulating, anti-inflammatory, analgesic, antiproliferative, inhibition of angiogenesis, repair of skin barrier, regulation of intestinal flora and other effects. It can play a therapeutic role in the pathogenesis of psoriasis immune regulation dis-orders, inflammatory infections, skin damage, intestinal flora disorders and so on, and provide sci-entific basis for clinical application.
文章引用：张自薇. 土茯苓活性成分治疗银屑病的作用机制研究进展[J]. 中医学, 2023, 12(10): 2910-2915. https://doi.org/10.12677/TCM.2023.1210437

参考文献

[1] 范九梅, 马卓. 土茯苓药学研究概述[J]. 安徽农业科学, 2018, 46(8): 36-37, 57. [Google Scholar] [CrossRef] 
[2] 赵磊. 土茯苓总黄酮与肠道菌群相互作用的研究[D]: [硕士学位论文]. 苏州: 苏州大学, 2020.[CrossRef] 
[3] 张清峰, 付莹娟, 黄占旺, 等. 土茯苓黄酮对高脂小鼠脂肪代谢及抗氧化水平的影响[J]. 现代食品科技, 2016, 32(11): 8-15.
[4] Lu, C.L., Zhu, W., Wang, M., Xu, X.J. and Lu, C.J. (2014) Antioxidant and Anti-Inflammatory Activities of Phenolic-Enriched Extracts of Smilax glabra. Evi-dence-Based Complementary and Alternative Medicine, 2014, Article ID: 910438. [Google Scholar] [CrossRef] [PubMed]
[5] 肖战说, 邹建华, 林建国, 等. 基于网络药理学与分子对接探讨土茯苓治疗银屑病的作用机制[J]. 世界中医药, 2022, 17(5): 658-663, 670.
[6] 狄伟, 吴然, 文昌晖, 等. 基于网络药理学探讨土茯苓治疗银屑病的作用机制[J]. 世界最新医学信息文摘(连续型电子期刊), 2020, 20(89): 14-17. [Google Scholar] [CrossRef] 
[7] 高思, 贾颖, 张皎皎. 基于网络药理学分析土茯苓治疗银屑病的作用机制[J]. 山西中医药大学学报, 2021, 22(4): 283-286, 290. [Google Scholar] [CrossRef] 
[8] 李腾飞, 周妍妍, 杨素清, 等. 土茯苓-槐花药对治疗银屑病作用机制的网络药理学研究[J]. 中国中医急症, 2022, 31(7): 1134-1139, 1184.
[9] 汤迎湛, 刘菊妍, 江振洲, 等. 土茯苓总苷化学成分研究[J]. 中草药, 2022, 53(22): 6977-6984.
[10] 刘淑艳, 王伟荣, 叶凌赟, 等. 土茯苓复方治疗口腔鳞状细胞癌的作用机制研究[J]. 浙江医学, 2023, 45(14): 1498-1504, 1511, 1571.
[11] 李蝉秀, 舒福, 王昕, 等. 基于数据挖掘和网络药理学探析血热型银屑病的用药规律与作用机制研究[J/OL]. 云南民族大学学报(自然科学版): 1-16, 2023-09-15. http://epub1.yyttgd.top/kcms/detail/53.1192.N.20220826.1718.007.html
[12] 夏琦, 邓时贵, 卢传坚. 土茯苓对环孢素A诱导的免疫抑制小鼠免疫功能的影响[J]. 中国现代应用药学, 2019, 36(21): 2638-2642. [Google Scholar] [CrossRef] 
[13] 夏琦. 土茯苓免疫调节作用的物质基础和机制研究[D]: [硕士学位论文]. 广州: 广州中医药大学, 2019.
[14] 王敏. 土茯苓中性杂多糖的分离纯化、结构解析及其免疫调节作用的研究[D]: [硕士学位论文]. 广州: 广州中医药大学, 2016.
[15] Singh, P., Arif, Y., Bajguz, A. and Hayat, S. (2021) The Role of Quercetin in Plants. Plant Physiology and Biochemistry, 166, 10-19. [Google Scholar] [CrossRef] [PubMed]
[16] 范兴达, 何冬梅. 红茴香及其活性成分治疗骨关节炎研究概况[J]. 中医药临床杂志, 2021, 33(10): 2019-2023.
[17] 王秀菊, 周丽娟, 王康民, 等. 基于IL-17/Notch轴土茯苓总黄酮对银屑病小鼠皮肤瘙痒缓解及炎症反应抑制的作用机制研究[J]. 天津中医药, 2022, 39(6): 794-800.
[18] Gong. G., Guan, Y.Y., Zhang, Z.L., et al. (2020) Isorhamnetin: A Review of Pharmacological Effects. Biomedicine & Pharmacotherapy, 128, Article ID: 110301. [Google Scholar] [CrossRef] [PubMed]
[19] Kim, J.H., Bae, H.C., Kim, J., et al. (2018) HIF-1α-Mediated BMP6 down-Regulation Leads to Hyperproliferation and Ab-normal Differentiation of Keratinocytes in vitro. Experimental Dermatology, 27, 1287-1293. [Google Scholar] [CrossRef] [PubMed]
[20] Rendon, A. and Schäkel, K. (2019) Psoriasis Pathogenesis and Treatment. The Journal of the American Medical Association, 20, Article 1475. [Google Scholar] [CrossRef] [PubMed]
[21] Sundarrajan, S., Nandakumar, M.P., Prabhu, D., Jeyaraman, J. and Arumugam, M. (2020) Conformational Insights into the Inhibitory Mechanism of Phyto-Compounds against Src Kinase Family Members Implicated in Psoriasis. Journal of Biomolecular Structure and Dynamics, 38, 1398-1414. [Google Scholar] [CrossRef] [PubMed]
[22] Yin, Y., Liu, X., Liu, J., Cai, E., Zhu, H., Li, H., Zhang, L., Li, P. and Zhao, Y. (2018) β-Sitosterol and Its Derivatives Repress Lipopolysaccharide/D-Galactosamine-Induced Acute Hepatic Injury by Inhibiting the Oxidation and Inflammation in Mice. Bioorganic & Medicinal Chemistry Letters, 28, 1525-1533. [Google Scholar] [CrossRef] [PubMed]
[23] 李俊辰, 申倩, 马育晓, 等. 基于网络药理学和分子对接技术的“土茯苓-茵陈”药对治疗银屑病作用机制的研究[J]. 中国中西医结合皮肤性病学杂志, 2021, 20(6): 533-539.
[24] 赵京霞, 李萍, 刘欣, 等. 理血解毒类方对寻常型银屑病患者外周血血管内皮生长因子水平的影响[J]. 首都医科大学学报, 2009, 30(4): 423-425.
[25] 向本旭, 刘婷婷, 孙芳玲, 等. VEGF相关信号通路在血管新生中的研究进展[J]. 中国比较医学杂志, 2015, 25(12): 81-86.
[26] 狄伟. 龙胆泻肝汤加味对豚鼠银屑病样皮损VEGF及ES表达的影响[J]. 湖南中医杂志, 2017, 33(4): 155-158.
[27] 张朋月, 强燕, 陈丽宏, 等. 泻肝凉血解毒方对豚鼠银屑病样皮损TNF-α的影响[J]. 上海中医药杂志, 2016, 50(10): 96-98, 102.
[28] Kayashima, H., Toshima, T., Okano, S., et al. (2010) Intratumoral Neoadjuvant Immunotherapy Using IL-12 and Dendritic Cells Is an Effective Strategy to Con-trol Recurrence of Murine Hepatocellular Carcinoma in Immunosuppressed Mice. Journal of Immunology, 185, 698-708. [Google Scholar] [CrossRef] [PubMed]
[29] Wigginton, J.M., Gruys, E., Geiselhart, L., et al. (2001) IFN-γ and Fas/FasL Are Required for the Antitumor and Antiangiogenic Effects of IL-12/Pulse IL-2 Therapy. Journal of Clinical Investigation, 108, 51-62. [Google Scholar] [CrossRef] 
[30] Yin, X., Yan, X., Yang, Q., Cao, H. and Liang, H. (2010) Antitumor Mechanism of Recombinant Murine Interleukin-12 Vaccine. Cancer Biotherapy & Radiopharmaceuticals, 25, 263-268. [Google Scholar] [CrossRef] [PubMed]
[31] Hanel, K.H., Cornelissen, C., Luscher, B., et al. (2013) Cytokines and the Skin Barrier. International Journal of Molecular Sciences, 14, 6720-6745. [Google Scholar] [CrossRef] [PubMed]
[32] Ishida-Yamamoto, A., Kishibe, M., Murakami, M., Honma, M., Takahashi, H. and Iizuka, H. (2012) Lamellar Granule Secretion Starts before the Establishment of Tight Junction Barrier for Paracellular Tracers in Mammalian Epidermis. PLOS ONE, 7, e31641. [Google Scholar] [CrossRef] [PubMed]
[33] 赵丽阳, 张艳飞, 郑瑞. 表皮极性及极性蛋白在银屑病中研究进展[J]. 中国医学创新, 2014(6): 143-146.
[34] Brandner, J.M., Zorn-Kruppa, M., Yoshida, T., et al. (2015) Epi-dermal Tight Junctions in Health and Disease. Tissue Barriers, 3, e974451. [Google Scholar] [CrossRef] [PubMed]
[35] 李双庚, 王红霞. 养血解毒方对寻常型银屑病患者皮肤屏障功能的影响[J]. 环球中医药, 2016, 9(9): 1130-1132.
[36] 李生存, 马文宇, 燕华玲. 解毒化瘀汤对银屑病患者的疗效及炎性因子水平的影响[J]. 中药材, 2014, 37(7): 1307-1309.
[37] 向志, 郝志敏, 崔盘根, 等. 肠道-微生物-皮肤轴与银屑病相关性的研究进展[J]. 皮肤性病诊疗学杂志, 2022, 29(6): 588-592.
[38] Scher, J.U., Ubeda, C., Artacho, A., et al. (2015) Decreased Bacterial Diversity Characterizes the Altered Gut Microbiota in Patients with Psori-atic Arthritis, Resembling Dysbiosis in Inflammatory Bowel Disease. Arthritis Rheumatology, 67, 128-139. [Google Scholar] [CrossRef] [PubMed]
[39] De Francesco, M.A. and Caruso, A. (2022) The Gut Microbiome in Psoria-sis and Crohn’s Disease: Is Its Perturbation a Common Denominator for Their Pathogenesis? Vaccines, 10, Article 244. [Google Scholar] [CrossRef] [PubMed]
[40] 翟春艳, 底婷婷, 王燕, 等. 健脾养血解毒方通过调节Treg/Th17免疫平衡改善脾虚-银屑病复合模型小鼠银屑病样皮损[J]. 中华中医药学刊, 2019, 37(12): 2888-2893.